Panagora Asset Management’s Rockwell Medical RMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$62.3K Buy
6,973
+246
+4% +$2.45K ﹤0.01% 1146
2025
Q4
$56.1K Sell
6,727
-129
-2% -$1.3K ﹤0.01% 1166
2025
Q3
$82.3K Buy
6,856
+2,016
+42% +$24.7K ﹤0.01% 1137
2025
Q2
$41K Buy
+4,840
New +$49.3K ﹤0.01% 1107
2021
Q1
Sell
-10
Closed -$1K 2911
2020
Q4
$1K Hold
10
﹤0.01% 2740
2020
Q3
$1K Buy
+10
New +$1.73K ﹤0.01% 2658
2014
Q2
Sell
-1
Closed -$2K 2381
2014
Q1
$2K Buy
+1
New +$1.3K ﹤0.01% 2314

Other funds holding RMTI

Panagora Asset Management's RMTI Position: Q1 2026 in Review

Panagora Asset Management increased its Rockwell Medical (RMTI) stake by 3.7% in Q1 2026, buying an estimated $2.45K and bringing the position to 6,973 shares worth $62.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1146.

Panagora Asset Management first reported a position in RMTI in Q1 2014 and has held it in 7 quarters since. The position peaked at $82.3K in Q3 2025. 42 funds tracked by Wall St. Rank hold RMTI as of Q1 2026.

  • Panagora Asset Management held 6,973 shares of Rockwell Medical worth $62.3K as of Q1 2026.
  • Panagora Asset Management bought 246 Rockwell Medical shares in Q1 2026, an estimated $2.45K.
  • Rockwell Medical made up ﹤0.01% of Panagora Asset Management's portfolio in Q1 2026, its #1146 holding.
  • Panagora Asset Management first reported a position in Rockwell Medical in Q1 2014 and has held it in 7 quarters since.
  • Panagora Asset Management's Rockwell Medical position peaked at $82.3K in Q3 2025.
  • 42 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2026.

Based on Panagora Asset Management's 13F filing for Q1 2026, filed 14 May 2026.